Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
04/2010
04/01/2010WO2010036698A1 Substituted alpha-l-bicyclic nucleosides
04/01/2010WO2010036696A1 Cyclohexenyl nucleic acid analogs
04/01/2010WO2010036323A1 Method of identifing interactions between genomic loci
04/01/2010WO2010034115A1 Thermostable alcohol dehydrogenase derived from thermococcus guaymasensis
04/01/2010WO2009139804A3 Biologically active recombinant human saposin c and psap
04/01/2010US20100083409 Expression vector comprising genetic insulator elements for enhancing transcription of insect resistance genes
04/01/2010US20100083408 Gene Expression Modulating Element
04/01/2010US20100083407 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
04/01/2010US20100083405 Method For Controlling Seed Germination In Non-Dormant Seeds And Use Thereof
04/01/2010US20100083403 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies
04/01/2010US20100083399 COMPOSITIONS AND METHODS FOR ASSAYING MARKERS TIGHTLY LINKED TO RESISTANCE LOCUS Bs2 OF PEPPER
04/01/2010US20100083396 Soybean Gene for Resistance to Aphis glycines
04/01/2010US20100083392 Hafnia phytase variants
04/01/2010US20100081801 Method for determining an unknown PNA sequence and uses thereof
04/01/2010US20100081793 Therapeutic uses of humanized antibodies against alpha-4 integrin
04/01/2010US20100081789 Novel Vectors for Production of Interferon
04/01/2010US20100081712 Recombinant human factor ix and use thereof
04/01/2010US20100081711 Cytotoxic agents
04/01/2010US20100081710 Modified L-Nucleic Acid
04/01/2010US20100081709 Isolated snare ykt6 genomic polynucleotide fragments from chomosome 7 and their uses
04/01/2010US20100081708 Anticoagulant compounds
04/01/2010US20100081706 Immunomodulatory oliogonucleotides and methods of use therefor
04/01/2010US20100081705 Methods for slowing familial als disease progression
04/01/2010US20100081704 Modulator compounds of the drug resistance in epithelial tumour cells
04/01/2010US20100081627 Polymeric nucleoside prodrugs
04/01/2010US20100081612 Polypeptide derivatives of parathyroid hormone (pth)
04/01/2010US20100081581 Probe, probe set, probe-immobilized carrier, and genetic testing method
04/01/2010US20100081211 Luminescent lanthanide labelling reagents and their use
04/01/2010US20100081204 Nucelic-acid-responsive gel, method for producing same, and use of same
04/01/2010US20100081198 Method for the repair of mutated rna from genetically defective dna and for the specific destruction of tumor cells by rna trans-splicing, and a method for the detection of naturally trans-spliced cellular rna
04/01/2010US20100081193 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
04/01/2010US20100081192 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use
04/01/2010US20100081147 Human catechol-o-methyltransferase (comt) assay
04/01/2010US20100081140 Chemically cleavable phosphoramidite linkers for sequencing by ligation
04/01/2010US20100081138 Nucleotide sequences for the detection of enterohaemorrhagic Escherichia coli (EHEC)
04/01/2010US20100081137 Click Chemistry for the Production of Reporter Molecules
04/01/2010US20100081133 Methods of Detecting Root Knot Nematodes
04/01/2010US20100081124 Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples
04/01/2010US20100080887 Soybean plant with altered oil content (more oleic, less saturated fat); cooking oil, salad oil, shortening, lecithin, nontoxic plastics, printing inks, lubricants, waxes, hydraulic fluids, electric transformer fluids, solvents, cosmetics, hair care products and biodiesel
04/01/2010US20100080850 Polypeptide ligands for targeting cartilage and methods of use thereof
04/01/2010US20100080828 Immunogenic sequences
04/01/2010US20100080817 HUMAN PAPILLOMAVIRUS / Ii-KEY HYBRIDS AND METHODS OF USE
04/01/2010US20100080815 MN Gene and Protein
04/01/2010US20100080813 Neutralizing anti-influenza a virus antibodies and uses thereof
04/01/2010US20100080812 Antibodies against human IL17 and uses thereof
04/01/2010US20100080809 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof
04/01/2010US20100080801 Comprises nucleotide sequences coding antibody receptor for treating autoimmune and immunological diseases
04/01/2010US20100080800 Humanized antibody
04/01/2010US20100080799 Wstf regulates the dna damage response of h2a.x via novel tyrosine kinase activity
04/01/2010US20100080794 Mutant polypeptide having effector function
04/01/2010US20100080774 Lactococcus promoters and uses thereof
04/01/2010CA2776044A1 Screening methods for identifying specific staphylococcus aureus inhibitors
04/01/2010CA2738574A1 Thermostable alcohol dehydrogenase derived from thermococcus guaymasensis
04/01/2010CA2738474A1 Soybean transgenic event mon87705 and methods for detection thereof
03/2010
03/31/2010EP2169076A2 Enzymes having alpha amylase activity and methods of use thereof
03/31/2010EP2168973A1 Nucleic acid ligand complexes
03/31/2010EP2167662A2 Pharmaceutical compounds comprising abasic oligonucleotides
03/31/2010EP2167524A1 Methods of directly amplifying nucleic acids from crude samples
03/31/2010CN101688327A Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death
03/31/2010CN101688239A Early detection and prognosis of colon cancers
03/31/2010CN101687901A corn polymorphisms and methods of genotyping
03/31/2010CN101687900A Double-stranded locked nucleic acid compositions
03/31/2010CN101687050A Methods and materials for identifying the origin of a carcinoma of unknown primary origin
03/31/2010CN101687005A Methods for treating cancer using agents that inhibit wnt16 signaling
03/31/2010CN101684147A moraxella catarrhalis proteins
03/31/2010CN101684138A Kit using nanometer magnetic beads for purifying nucleic acid
03/31/2010CN101684137A Method for extracting total DNA of microorganism in liquor Daqu
03/30/2010US7687618 Method of manufacturing labelled oligonucleotide conjugates
03/30/2010US7687617 Oligonucleotides with alternating segments of locked and non-locked nucleotides
03/30/2010US7687616 for therapy that allows inter alia up-regulation of a disease-related target gene of novel GAM oligonucleotides of the present invention, by countering the activity of a GAM oligonucleotides which naturally inhibits expression of that target gene
03/30/2010US7687615 PAV regions for encapsidation and E1 transcriptional control
03/30/2010US7687614 Monomeric and dimeric fluorescent protein variants and methods for making same
03/30/2010US7687610 having an increased activity over the wild-type human glycoprotein; reproduction disorders; cancer such as thyroid carcinoma
03/30/2010US7687475 RNA interference in respiratory epithelial cells
03/30/2010US7687256 bioanalytical microarray comprising surface with microlocations in discrete regions and forms pattern; each microlocation has dose density of implanted ions and functions as potential energy location; exhibits affinity for compound different from surface; plurality of macromolecules in microlocations
03/30/2010US7687254 homogenizing biological material with homogenization buffer to form homogenate; proteins and non-DNA organic molecules are extracted from homogenate by mixing first extraction buffer and second extraction buffer with the homogenate; DNA is precipitated from mixture, recovered by sedimentation
03/30/2010US7687253 Escherichia coli strains which over-produce L-threonine and processes for the production of L-threonine by fermentation
03/30/2010US7687247 Process for controlling contamination of nucleic acid amplification reactions
03/30/2010US7687236 Fluorescent nucleobase conjugates having anionic linkers
03/30/2010US7687233 Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin K epoxide reductase gene and warfarin dosage
03/30/2010US7687058 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
03/30/2010CA2491887C Modified inosine monophosphate dehydrogenases
03/30/2010CA2409347C Enhanced protein thermostability and temperature resistance
03/30/2010CA2403326C Methods of protein detection utilizing cleavable identifying tags
03/30/2010CA2170523C Cloned glutamic acid decarboxylase
03/30/2010CA2162150C Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene
03/30/2010CA2155004C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
03/30/2010CA2144223C Effector proteins of rapamycin
03/30/2010CA2139070C Method for enhancing detection ability of nucleic acid assays employing polymerase chain reaction
03/25/2010WO2010034024A2 Protected monomers and methods of deprotection for rna synthesis
03/25/2010WO2010033753A2 Mutant delta5 desaturases and their use in making polyunsaturated fatty acids
03/25/2010WO2010033688A2 Nucleic acids encoding spider glue proteins and methods of use thereof
03/25/2010WO2010033667A2 Wstf regulates the dna damage response of h2a.x via novel tyrosine kinase activity
03/25/2010WO2010033652A1 Method for small rna isolation
03/25/2010WO2010033619A2 Systems, methods, and compositions for detection of human papilloma virus in biological samples
03/25/2010WO2010033225A2 Compositions and methods for the specific inhibition of gene expression by dsrna possessing modifications
03/25/2010WO2010014572A3 Modulation of toll-like receptor 9 expression by antisense oligonucleotides
03/25/2010WO2009149253A3 Mrna cap analogs
03/25/2010WO2009131919A8 Polymerases for incorporating modified nucleotides
03/25/2010WO2009099580A3 Transgenic soy plants with enhanced agronomic traits